Last reviewed · How we verify
NCT06921551
Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis
NA trial testing ABLE Exoskeleton in Multiple Sclerosis in 19 participants. Participants enrolled and being followed up; not accepting new ones.
7 May 2026
Quick facts
| Lead sponsor | ABLE Human Motion S.L. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 19 |
| Start date | 7 April 2025 |
| Primary completion | 7 May 2026 |
| Estimated completion | 7 May 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- ABLE Exoskeleton
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
ABLE Human Motion S.L.
Who can join
Adults 18 to 70, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is: Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis? Participants will: * Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic * Have an evaluation (tests and questionnaires) every 3 months at the clinic
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06921551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ABLE Exoskeleton
Trials testing the same drug.
- NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S · NA · recruiting
- NCT07050875 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquir · NA · completed
- NCT06261541 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multip · NA · completed
- NCT05643313 — Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Inju · NA · completed
- NCT05590065 — Clinical Investigation on the Impact on Safety, Feasibility and Usability of the Design Changes Performed on ABLE Exoske · NA · completed
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other ABLE Human Motion S.L. trials
Trials by the same sponsor.
- NCT07036107 — A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the S · NA · recruiting
- NCT07050875 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquir · NA · completed
- NCT07062575 — Exoskeleton Training at Home to Assist Participants With Spinal Cord Injuries to Perform Ambulatory Functions. · NA · suspended
- NCT06261541 — Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multip · NA · completed
- NCT05643313 — Clinical Investigation on Feasibility and Usability of the ABLE Exoskeleton Device for Individuals With Spinal Cord Inju · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06921551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ABLE Human Motion S.L.
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06921551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing